Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68755-37-3

Post Buying Request

68755-37-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68755-37-3 Usage

General Description

6-(Trifluoromethyl)-1-indanone is a chemical compound with the molecular formula C10H7F3O. It is a white to light yellow solid that is commonly used as an intermediate in the pharmaceutical and agrochemical industries. 6-(Trifluoromethyl)-1-indanone is often employed in the synthesis of various pharmaceuticals, such as anti-inflammatory agents and antipsychotic drugs. It is also utilized as a building block for the production of specialty chemicals and fine chemicals. Additionally, 6-(Trifluoromethyl)-1-indanone has applications in the field of organic chemistry, where it serves as a versatile synthetic building block for the construction of more complex molecules. Overall, this compound plays a significant role in the development of various important chemical and pharmaceutical products.

Check Digit Verification of cas no

The CAS Registry Mumber 68755-37-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,7,5 and 5 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 68755-37:
(7*6)+(6*8)+(5*7)+(4*5)+(3*5)+(2*3)+(1*7)=173
173 % 10 = 3
So 68755-37-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H7F3O/c11-10(12,13)7-3-1-6-2-4-9(14)8(6)5-7/h1,3,5H,2,4H2

68755-37-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 6-(Trifluoromethyl)-1-indanone

1.2 Other means of identification

Product number -
Other names 6-(trifluoromethyl)-2,3-dihydroinden-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68755-37-3 SDS

68755-37-3Relevant articles and documents

GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 001241; 001245; 001261; 001262, (2021/01/22)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with a defect in glyoxylate metabolism, for example a disease or disorder associated with the enzyme glycolate oxidase (GO) or alterations in oxalate metabolism. Such diseases or disorders include, for example, disorders of glyoxylate metabolism, including primary hyperoxaluria, that are associated with production of excessive amounts of oxalate.

Recyclable Hypervalent-Iodine-Mediated Dehydrogenative α,β′-Bifunctionalization of β-Keto Esters under Metal-Free Conditions

Duan, Ya-Nan,Cui, Li-Qian,Zuo, Lin-Hong,Zhang, Chi

supporting information, p. 13052 - 13057 (2015/09/07)

We have developed a method for recyclable hypervalent-iodine-mediated direct dehydrogenative α,β′- bifunctionalization of β-ketoesters and β-diketones under metal-free conditions, which affords a straightforward way to synthesize benzo-fused 2,3-dihydrofurans. This efficient, mild method, which has a wide substrate scope and good functional-group tolerance, was used for the multistep synthesis of the protected aglycone of a naturally occurring phenolic glycoside. A mechanism involving Michael addition to an enone intermediate and subsequent oxidative cyclization is proposed.

Piperazinylpiperidine derivatives as chemokine receptor antagonists

-

Page/Page column 22, (2008/06/13)

The present invention relates to compounds of Formula I: wherein variable substituents are defined herein, that modulate the activity of or bind to chemokine receptors such as CCR5. In some embodiments, the compounds of the invention are selective for CCR

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68755-37-3